• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Prevalence of Medical and Psychiatric Comorbidities in Paediatric ARFID: A Meta‐Analysis

ABSTRACT

Background

Avoidant/Restrictive Food Intake Disorder (ARFID) is increasingly recognized as a complex paediatric feeding and eating disorder associated with significant medical and psychiatric burden.

Methods

This systematic review and meta-analysis followed PRISMA guidelines and was prospectively registered in PROSPERO (CRD420251241490). PsycINFO, PubMed, Scopus, and Web of Science were searched. Observational and clinical studies reporting medical and/or psychiatric comorbidities in paediatric ARFID samples were included. Random-effects models generated pooled prevalence estimates; heterogeneity, publication bias, and evidence certainty were evaluated using I
2, Egger’s test, and GRADE, respectively.

Results

Eighty-four studies met inclusion criteria. Gastrointestinal disorders (30%; 95% CI: 21%–42%) and nutritional deficiencies (32%; 95% CI: 23%–42%) were the most prevalent medical comorbidities. Food allergies were present in 15% (95% CI: 9%–23%). Among psychiatric conditions, anxiety disorders were most common (44%; 95% CI: 39%–49%), followed by depression (18%; 95% CI: 15%–21%), autism spectrum disorder (19%; 95% CI: 15%–24%), attention-deficit/hyperactivity disorder (15%; 95% CI: 13%–18%), and obsessive–compulsive disorder (11%; 95% CI: 9%–13%). Heterogeneity was high across outcomes (I
2 ≥ 75%). Publication bias was detected for anxiety, depression, and nutritional deficiencies. Overall certainty of evidence ranged from very low to low.

Conclusions

Paediatric ARFID is associated with substantial medical and psychiatric comorbidity, particularly anxiety and neurodevelopmental conditions. Findings support comprehensive, multidisciplinary assessment and developmentally informed interventions. Further high-quality, population-based studies are needed to reduce heterogeneity and strengthen evidence certainty.

Read the full article ›

Posted in: Meta-analyses - Systematic Reviews on 11/13/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice